Controlling the thickness of polymeric shell on magnetic nanoparticles loaded with doxorubicin for targeted delivery and MRI contrast agent

Carbohydrate Polymers

Volumn 87, Issue 4, 2012, Pages 2593-2604

  Sahu, Sumanta Kumar ^a   Maiti, Swatilekha ^a   Pramanik, Arindam ^a   Ghosh, Sudip Kumar ^a   Pramanik, Panchanan ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Cancer therapy; Chitosan; Doxorubicin; Magnetic nanoparticles; Targeted drug delivery

Indexed keywords

CHITIN; CHITOSAN; DISEASES; FLUORESCENCE; FLUORESCENCE MICROSCOPY; MAGNETIC RESONANCE IMAGING; MAGNETISM; NANOPARTICLES; POLYMERS; SHELLS (STRUCTURES); SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

CANCER THERAPY; CONTRAST ENHANCEMENT; CORE SHELL STRUCTURE; DOXORUBICIN; MAGNETIC NANO-PARTICLES; MAGNETIC NANOPARTI CLES (MNPS); MRI CONTRAST AGENTS; SUPERPARAMAGNETIC IRON OXIDES;

NANOMAGNETICS;

EID: 84865464358     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2011.11.033     Document Type: Article

References (40)

1. Bahadur, K. C., Lee, S. M., Yoo, E. S., Choi, J. H., & Ghim, H. D. (2009). Glycoconjugated chitosan stabilized iron oxide nanoparticles as a multifunctional nanoprobe. Materials Science and Engineering C, 29, 1668-1673.
2. Basti, H., Tahar, L. B., Smiri, L. S., Herbst, F., Vaulay, M., Chau, F., Ammara, S., & Benderbous, S. (2010). Catechol derivatives-coated Fe3O4 and γ-Fe2O3 nanoparticles as potential MRI contrast agents. Journal of Colloid and Interface Science, 341, 248-254.
3. Belessi, V., Zboril, R., Tucek, J., Mashlan, M., Tzitzios, V., & Petridis, D. (2008). Ferrofluids from magnetic-chitosan hybrids. Chemistry of Materials, 20, 3298-3305.
4. Chen, S., Li, Y., Guo, C., Wang, J., Ma, J., Liang, X., Yang, L. R., & Liu, H. Z. (2007). Temperature-responsive magnetite/PEO-PPO-PEO block copolymer nanoparticles for controlled drug targeting delivery. Langmuir, 23, 12669-12676. (Pubitemid 350275586)
5. Das, M., Mishra, D., Dhak, P., Gupta, S., Maiti, T. K., Basak, A., & Pramanik, P. (2009). Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging. Small, 5, 2883-2893.
6. Das, M., Mishra, D., Maiti, T. K., Basak, A., & Pramanik, P. (2008). Bio-functionalization of magnetite nanoparticles using an aminophosphonic acid coupling agent: New, ultradispersed, iron-oxide folate nanoconjugates for cancer-specific targeting. Nanotechnology, 19, 415101-415115.
7. Dilnawaz, F., Singh, A., Mohanty, C., & Sahoo, S. K. (2010). Dual drug loaded superparamagnetic iron oxide NPs for targeted cancer therapy. Biomaterials, 31, 3694-3706.
8. Dobson, J. (2006). Magnetic nanoparticles for drug delivery. Drug Development Research, 67, 55-60. (Pubitemid 43765049)
9. Fang, C., & Zhang, M. Q. (2009). Multifunctional magnetic nanoparticles for medical imaging applications. Journal of Materials Chemistry, 19, 6258-6266.
10. Forster, D., Washington, C., & Davis, S. S. (1988). Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes. Journal of Pharmacy and Pharmacology, 40, 325-328.
11. Hafeli, U., Riffle, J. S., Harris-Shekhawat, L., Carmichael-Baranauskas, A., Mark, F., Dailey, J. P., & Bardenstein, D. (2009). Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Molecular Pharmaceutics, 6, 1417-1428.
12. Hamoudeh, M., Faraj, A. A., Canet-Soulas, E., Bessueille, F., Leonard, D., & Fessi, H. (2007). Elaboration of PLLA-based superparamagnetic nanoparticles: Characterization, magnetic behaviour study and in vitro relaxivity evaluation. International Journal of Pharmaceutics, 338, 248-257. (Pubitemid 46783978)
13. Jain, T. K., Morales, M. A., Sahoo, S. K., Leslie-Pelecky, D. L., & Labhasetwar, V. (2005). Iron oxide nanoparticles for sustained delivery of anticancer agents. Molecular Pharmaceutics, 2, 194-205. (Pubitemid 40917416)
14. Kim, D. H., Kim, K. N., Kim, K. M., & Lee, Y. K. (2009). Targeting to carcinoma cells with chitosan-and starch-coated magnetic nanoparticles for magnetic hyperthermia. Journal of Biomedical Materials Research Part A, 88A, 1-11.
15. Kohler, N., Fryxell, G. E., & Zhang, M. (2004). A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. Journal of American Chemical Society, 126, 7206-7211. (Pubitemid 38747770)
16. Leamon, C., & Low, P. (1994). Selective targeting of malignant-cells with cytotoxinfolate conjugates. Journal of Drug Targeting, 2, 101-112. (Pubitemid 24194288)
17. Liang, X. F., Wang, H. J., Luo, H., Tian, H., Zhang, B. B., Hao, L. J., Teng, J. I., & Chang, J. (2008). Characterization of novel multifunctional cationic polymeric liposomes formed from octadecyl quaternized carboxymethyl chitosan/cholesterol and drug encapsulation. Langmuir, 24, 7147-7153.
18. Lin, J. J., Chen, J. S., Huang, S. J., Ko, J. H., Wang, Y. M., Chen, T. L., & Wang, L. F. (2009). Folic acid-pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials, 30, 5114-5124.
19. Ling, Y., Naggar, A. K., Priebe, W., & Perez-Soler, R. (1996). Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Molecular Pharmacology, 49, 832-841.
20. Liu, T. Y., Chen, S. Y., Lin, Y. L., & Liu, D. M. (2006). Synthesis and characterization of amphiphatic carboxymethyl-hexanoyl chitosan hydrogel: Water-retention ability and drug encapsulation. Langmuir, 22, 740-745.
21. McCarthy, J. R., Kelly, K. A., Sun, E. Y., & Weissleder, R. (2007). Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine, 2, 153-167. (Pubitemid 46850565)
22. Mohapatra, S., Mallick, S. K., Maiti, T. K., Ghosh, S. K., & Pramanik, P. (2007). Synthesis of highly stable folic acid conjugated magnetite nanoparticles for targeting cancer cells. Nanotechnology, 18, 385102-385111.
23. Morris, V. B., & Sharma, C. P. (2010). Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector. International Journal of Pharmaceutics, 389, 176-185.
24. Narain, R., Gonzales, M., Hoffman, A. S., Stayton, P. S., & Krishnan, K. M. (2007). Synthesis of monodisperse biotinylated p (NIPAAm)-coated iron oxide magnetic nanoparticles and their bioconjugation to streptavidin. Langmuir, 23, 6299-6304. (Pubitemid 46868704)
25. Okassa, L. N., Marchais, H., Douziech-Eyrolles, L., Herve, K., Cohen-Jonathan, S., Munnier, E., Souce, M., Linassier, C., Dubois, P., & Chourpa, I. (2007). Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles. European Journal of Pharmaceutics and Biopharmaceutics, 67, 31-38. (Pubitemid 46991326)
26. Park, J. H., Maltzahn, G., Zhang, L., Schwartz, M. P., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2008). Magnetic iron oxide nanoworms for tumor targeting and imaging. Advanced Materials, 20, 1630-1635.
27. Prabaharan, M., & Gong, S. (2008). Novel thiolated carboxymethyl chitosan-g-bcyclodextrin as mucoadhesive hydrophobic drug delivery carriers. Carbohydrate Polymers, 73, 117-125.
28. Qian, F., Cui, F., Ding, J., Tang, C., & Yin, C. (2006). Chitosan graft copolymer nanoparticles for oral protein drug delivery: Preparation and characterization. Biomacromolecules, 7, 2722-2727. (Pubitemid 44615253)
29. Sahu, S. K., Maiti, S., Maiti, T. K., Ghosh, S. K., & Pramanik, P. (2010). Folate decorated succinyl chitosan nanoparticles conjugated with doxorubicin for targeted drug delivery. Macromolecular Bioscience, 11, 285-295.
30. Sahu, S. K., Maiti, S., Maiti, T. K., Ghosh, S. K., & Pramanik, P. (2011). Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel. Journal of Drug Targeting, 19, 104-113.
31. Sun, T., Xu, P. X., Liu, Q., Xue, J., & Xie, W. M. (2003). Graft copolymerization of methacrylic acid onto carboxymethyl chitosan. European Polymer Journal, 39, 189-192. (Pubitemid 35432677)
32. Thierry, B., Kujawa, P., Tkaczyk, C., Winnik, F. M., Bilodeau, L., & Tabrizian, M. (2005). Delivery platform for hydrophobic drugs: Prodrug approach combined with self-assembled multilayers. Journal of American Chemical Society, 127, 1626-1627. (Pubitemid 40229134)
33. Thierry, B., Winnik, F. M., Merhi, Y., Silver, J., & Tabrizian, M. (2003). Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. Biomacromolecules, 4, 1564-1571. (Pubitemid 37455567)
34. Wan, S., Huang, J., Guo, M., Zhang, H., Cao, Y., Yan, H., & Liu, K. (2007). Biocompatible superparamagnetic iron oxide nanoparticle dispersions stabilized with poly (ethylene glycol)-oligo (aspartic acid) hybrids. Journal of Biomedical Materials Research Part A, 80A, 946-954.
35. Wout, Z. G., Pec, E. A., Maggiore, J. A., Williams, R. H., Palicharla, P., & Johnston, T. P. (1992). Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats. Journal of Parenteral Science and Technology, 46, 192-200. (Pubitemid 23052584)
36. Xie, W. M., Xu, P. X., & Wang, W. (2002). Preparation and antibacterial activity of a water-soluble chitosan derivative. Carbohydrate Polymers, 50, 35-40. (Pubitemid 34614114)
37. Zhang, J. L., Srivastava, R. S., & Misra, R. D. K. (2007). Core-shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: Synthesis, characterization, and LCST of viable drug-targeting delivery system. Langmuir, 23, 6342-6351. (Pubitemid 46868710)
38. Zhang, L., He, R., & Gu, C. (2006). Oleic acid coating on the monodisperse magnetite nanoparticles. Applied Surface Science, 253, 2611-2617. (Pubitemid 44820534)
39. Zheng, Y., Cai, Z., Song, X., Yu, B., Bi, Y., Chen, Q., Zhao, D., Xu, J., & Ho, S. (2009). Receptor mediated gene delivery by folate conjugated Ntrimethyl chitosan in vitro. International Journal of Pharmaceutics, 382, 262-269.
40. Zunino, F., & Capranico, G. (1990). DNA topoisomerase II as the primary target of anti-tumor anthracyclines. Anti-Cancer Drug Design, 5, 307-317.